The report provides a detailed analysis essential for establishing a Dirithromycin production plant. It encompasses all critical aspects necessary for Dirithromycin production, including the cost of Dirithromycin production, Dirithromycin plant cost, Dirithromycin production costs, and the overall Dirithromycin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Dirithromycin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Dirithromycin is a member of the macrolide antibiotic class, and it is used for multiple bacterial infections, including skin, respiratory tract, and other area infections. It is often used in the management of diseases such as bronchitis, sore throat (acute tonsillitis or pharyngitis), pneumonia, and skin infections. Additionally, it is utilized for the treatment of otitis media (middle ear infections). It functions by inhibiting the growth of the bacteria that cause such infections.
The market for Dirithromycin is driven by its application as an antibiotic used for the treatment of bacterial infections, which significantly promotes its demand in the pharmaceutical and medical industries. The widespread occurrence of bacterial infections is significantly increasing the demand for Dirithromycin. The drug’s ability to be effective against a variety of bacteria makes it a versatile option for the treatment of a broad range of bacterial infections, amplifying its market appeal.
Additionally, it is administered orally, which makes it more convenient than antibiotics that are administered intravenously, thereby boosting its demand. Overall, industrial Dirithromycin procurement is influenced by its application in the pharmaceutical and medical industries, rising cases of bacterial infections, broad-spectrum of applications, convenient administration, increasing healthcare awareness, and regulatory approvals.
Raw Material for Dirithromycin Production
According to the Dirithromycin production plant project report, the key raw material used in the production of Dirithromycin includes erythromycin.
Production Process of Dirithromycin
The extensive Dirithromycin production cost report consists of the following major industrial production process:
- Production from erythromycin: The production process of Dirithromycin starts with the reaction of erythromycin with hydroxylamine hydrochloride under reflux conditions to form an intermediate. The imine group of the intermediate undergoes reduction to an amine by using sodium borohydride to form 9(S)-Erythromycylamine. The resulting compound further undergoes a nucleophilic addition reaction with 2-(2-Methoxyethoxy)acetaldehyde to produce Dirithromycin as the final product.
Dirithromycin, commercially known as Dynabac or Norton, is a white to off-white crystalline powder having the molecular formula C42H78N2O14 and a molecular weight of 835.1 g/mol. It has a melting point in the range of 186 to 189 °C. It has an estimated water solubility of 0.23 mg/mL. It has better solubility in organic solvents. It has a log P value of around 1.6. The value of its dissociation constant, pKa, is 12.49. It is administered orally and acts as a lipid-soluble prodrug for (9S)-erythromycyclamine.
During intestinal absorption, Dirithromycin is hydrolyzed to produce the microbiologically active erythromycylamine. It is a macrolide antibiotic used to treat infections of the skin, soft tissues, and respiratory tract that are brought on by gram-negative, such as H. influenzae, L. pneumophila, M. catarrhalis, and M. pneumoniae, and gram-positive, such as S. aureus, S. pneumonia, and pyogenes.
